Cronos Group Inc. (NASDAQ:CRON - Get Free Report) reached a new 52-week low during trading on Monday . The company traded as low as $1.78 and last traded at $1.82, with a volume of 2332484 shares changing hands. The stock had previously closed at $1.82.
Cronos Group Trading Down 1.4 %
The company has a market capitalization of $690.47 million, a P/E ratio of -13.88, a PEG ratio of 1.74 and a beta of 0.89. The business has a 50 day moving average price of $1.93 and a 200 day moving average price of $2.03.
Hedge Funds Weigh In On Cronos Group
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Tower Research Capital LLC TRC raised its stake in Cronos Group by 140.5% during the 4th quarter. Tower Research Capital LLC TRC now owns 13,726 shares of the company's stock worth $28,000 after buying an additional 8,019 shares during the period. Thompson Davis & CO. Inc. bought a new position in shares of Cronos Group during the 4th quarter valued at about $29,000. SBI Securities Co. Ltd. acquired a new position in shares of Cronos Group in the 4th quarter valued at approximately $30,000. Jones Financial Companies Lllp increased its stake in Cronos Group by 64.5% during the 4th quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company's stock worth $34,000 after purchasing an additional 6,520 shares in the last quarter. Finally, Quantbot Technologies LP acquired a new stake in Cronos Group during the 3rd quarter worth approximately $37,000. 8.71% of the stock is owned by institutional investors.
About Cronos Group
(
Get Free Report)
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Featured Articles
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
